RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Agyare, Edward
PropertyValue
overview I began my quest for a medical research career with bachelors and masters degrees from the University of Science and Technology, Ghana; and followed through with another masters and a doctorate in Pharmaceutics from Florida A&M University. My prior experience has groomed me to be a multidisciplinary researcher seeking to bridge the divide between fields as disparate as pharmaceutics, neurobiology and nanotechnology – my doctoral research work focused on the development of a theranostic nanovehicle capable of targeting amyloid deposits in the cerebrovasculature. The nanovehicle was designed to consist of cyclophosphamide and magnevist (Gd-DTPA) in its core with biosensor grafted on its surface that specifically recognizes and docks to amyloid plaques. These investigations form the basis of very original techniques to address issues of nanoparticle penetration of the blood brain barrier, quantifying drug release within the brain and imaging nanoparticle biodistribution and pharmacokinetics. My extensive research experience on interaction of nanoparticles and ionizing radiation in treating pancreatic cancer as a postdoctoral fellow at Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX has unraveled a means of generating radiation dose enhancement using clinically relevant (low) concentrations of systemically administered bioconjugated gold nanoparticles, a finding that has tremendous translational significance. I have no doubt that I have the skills and the motivation to become a successful, independent and innovative pancreatic cancer researcher.
One or more keywords matched the following items that are connected to Agyare, Edward
Item TypeName
Academic Article Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits.
Academic Article Delivery of Polymeric Nanoparticles to Target Vascular Diseases.
Academic Article In vitro and in vivo antitumor activity of gemcitabine loaded thermosensitive liposomal nanoparticles and mild hyperthermia in pancreatic cancer.
Academic Article Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines.
Academic Article Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse.
Academic Article Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
Academic Article Evaluation of in-vitro cytotoxic effect of 5-FU loaded-chitosan nanoparticles against spheroid models.
Academic Article Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI.
Academic Article Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells.
Academic Article Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy.
Concept Nanoparticles
Academic Article American Association of Pharmaceutical Scientists Meeting
Academic Article Biomolecular Research & Therapeutics
Academic Article Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
Academic Article Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain.
Academic Article Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer.
Academic Article Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
Search Criteria
  • Nanoparticles
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support